Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov-Dec;12(11-12):21-5.

Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases

Affiliations

Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases

Farid Talih et al. Innov Clin Neurosci. 2015 Nov-Dec.

Abstract

The misuse of nootropics-any substance that may alter, improve, or augment cognitive performance, mainly through the stimulation or inhibition of certain neurotransmitters-may potentially be dangerous and deleterious to the human brain, and certain individuals with a history of mental or substance use disorders might be particularly vulnerable to their adverse effects. We describe four cases of probable nootropic-induced psychiatric adverse effects to illustrate this theory. To the best of our knowledge this has not been previously reported in the formal medical literature. We briefly describe the most common classes of nootropics, including their postulated or proven methods of actions, their desired effects, and their adverse side effects, and provide a brief discussion of the cases. Our objective is to raise awareness among physicians in general and psychiatrists and addiction specialists in particular of the potentially dangerous phenomenon of unsupervised nootropic use among young adults who may be especially vulnerable to nootropics' negative effects.

Keywords: Nootropics; cognitive enhancers; psychiatric adverse effects; substance abuse; substance misuse; supplements.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nishizaki T, Matsuoka T, Nomura T, et al. A long-term, potentiation-like facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam. Brain Res. 1999;826:281–288. - PubMed
    1. Turner DC, Robbins TW, Clark L, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology. 2003;165(3):260–269. - PubMed
    1. Turner DC, Clark L, Dowson J, et al. Modafinil improves cognition and response inhibition in adult attention- deficit/hyperactivity disorder. Biol Psychiatry. 2004;55:1031–1040. - PubMed
    1. Ferraro L, AntonelliT, Tanganelli S, et al. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology. 1999;20:346–356. - PubMed
    1. Darwish M, Kirby M, Hellriegel ET. Robertson P Jr. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives. Clin Drug Investig. 2009;29(9):613–623. - PubMed

LinkOut - more resources